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Abstract
Introduction: Recurrent hemorrhagic pericardial effusion in children with no identifiable cause is a rare
presentation.
Case presentation: We report the case of a 4-year-old Indian girl who presented with recurrent hemorrhagic
pericardial effusion. Diffuse lymphangiomatosis was suspected when associated pulmonary involvement, soft tissue
mediastinal mass, and lytic bone lesions were found. Pericardiectomy and lung biopsy confirmed the diagnosis of
diffuse lymphangiohemangiomatosis. Partial clinical improvement occurred with thalidomide and low-dose
radiotherapy, but our patient died from progressive respiratory failure.
Conclusion: Diffuse lymphangiohemangiomatosis should be considered in the differential diagnosis of
hemorrhagic pericardial effusion of unclear cause.
Introduction
Recurrent hemorrhagic pericardial effusion (HPE) is
u n c o m m o ni nc h i l d r e n .V i r a lp e r icarditis, tuberculosis,
neoplasm, connective tissue disease and drugs are typi-
cally responsible for HPE. We report a case of recurrent
HPE that posed diagnostic and therapeutic challenges.
Case presentation
A 4-year-old Indian girl was referred to us with a diag-
nosis of hemorrhagic pericardial effusion that recurred
despite aspiration twice in the past 6 months. The child
had insidious onset of breathlessness for six months and
had episodes of lower respiratory tract infection. Peri-
cardial effusion was detected on chest X-ray and hemor-
rhagic fluid was aspirated. She was started on
antitubercular drugs with steroids, but her condition did
not improve significantly. Our patient had normal devel-
opment in her early infancy stage and normal growth
prior to this illness. There was no family history of heart
disease, developmental defects, tuberculosis or connec-
tive tissue disease.
On examination, our patient was found to be in mild
respiratory distre s s .S h eh a dah e a r tr a t eo f1 1 0 / m t ,B P
of 90/60, respiratory rate of 30/mt, temperature of 37°C,
and oxygen saturation of 96%. Her weight was 14 kg
and her height was 110 cm. There were few basal
crackles in her lungs and her heart sounds were distant.
Chest X-ray showed marked cardiomegaly and streaky
lung fields (Figure 1). Her hemoglobin count was 8.7
gm/dl, and her total leukocyte count (TLC) was 10600/
mm
3 with 65% neutrophils. An echocardiogram showed
large pericardial effusion (2.0 cm circumferentially) with
evidence of tamponade. There was no structural lesion
in her lungs. A total of 300 ml of hemorrhagic pericar-
dial fluid was aspirated with a pigtail catheter in the
pericardium. The pericardial fluid showed numerous red
blood cells (RBCs) but no malignant cells were found.
The adenosine deaminase in the fluid was not elevated.
The bacterial and fungal cultures were sterile. Results of
her abdominal ultrasound examination were normal.
The fluid in our patient’s lungs re-accumulated within
weeks of drainage. The antitubercular treatment and
steroids were stopped. Meanwhile, results of her thyroid
function tests were normal. Her rheumatoid factor, anti-
nuclear antibodies, and antineutrophilic cytoplasmic anti-
bodies were negative. She tested negative for human
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High-resolution computed tomography (HRCT)
scan showed peculiar diffuse polygonal lobular architect
(Figure 2) and soft tissue mediastinal mass. A needle
biopsy of the mediastinal mass revealed only fat and con-
nective tissues. Repeated pericardial fluid analyses for
malignant cells were negative. Her platelet counts were
50 to 70,000/mm
3 on multiple occasions. She also tested
negative for disseminated intravascular coagulation
(DIC). Her bone marrow was normal.
The diagnosis was unclear. A review of literature on
similar HRCT picture [1] prompted a skeletal survey
which showed lytic lesions in her bones (Figure 3). Con-
sequently, diffuse multisystem involvement, lytic bone
lesions and HRCT findings led to the diagnosis of dif-
fuse lymphangiomatosis. The triglyceride levels in our
patient’s pericardial fluid were high, but her pericardial
fluid was always hemorrhagic. During the course of her
illness, she required multiple pericardiocentesis due to
the large reaccumulation of fluid, as well as respiratory
distress. Multiple blood transfusions were also given to
our patient.
Treatment with interferon alpha was discussed but her
parents did not consent to it. Thalidomide (50 mg/d),
octreotide and epsilon-aminocaproic acid were tried
empirically, but her response to this treatment was not
sustained. Low-dose radiotherapy of 20 Gy over 10 days
were also given to her pericardium. A pericardiectomy
was done after exhausting all options. Lung biopsy taken
at that time showed diffuse hemangiolymphangiomatosis
(Figure 4). There were numerous anastomotic proliferat-
ing, and cystic spaces in the pulmonary interstitium were
lined by endothelial cells. The cells lining the spaces were Figure 1 Chest X-ray shows enlarged heart and increased
markings in both lung fields.
Figure 2 High-resolution computed tomography image of the
chest shows thickened interlobular septae with typical
polygonal appearance of secondary pulmonary lobule. Small
amount of pleural fluid is seen.
Figure 3 A coronal computed tomography shows osteolytic
lesion in the lower third of right femur.
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Page 2 of 4CD31+, which is a marker of endothelial cells, although it
does not differentiate vascular from lymphatic capillaries.
Many of her capillaries contained blood. The connective
tissue stroma was predominantly lymphoid. Our patient’s
pericardium also showed similar findings. A diagnosis of
diffuse lymphangiohemangiomatosis was thus made. Our
patient had progressive respiratory failure and died after
two months.
Discussion
Diffuse lymphangiomatosis is a rare, non-malignant but
locally infiltrative multisystem disease that may involve
any tissue except the brain [2]. The thorax, bones, and
spleen are typically involved. The clinical course is
highly variable, but disease occurrence and lung involve-
ment in children suggest a poorer prognosis. To the
best of our knowledge, lymphangiohemangioma present-
ing with recurrent hemorrhagic pericardial effusion has
not been reported previously. The diagnosis in our case
was delayed until we were able to recognize the multi-
system nature of our patient’s disease. A chylous peri-
cardial effusion might have led to an earlier diagnosis,
but the hemorrhagic effusion resulted from the heman-
giomatous component of the angioma in the
pericardium.
The histologic differentiation of lymphangiomatosis
from hemangiomatosis is not always easy and the total
picture favoured the label of lymphangiohemangiomato-
sis. In retrospect, this is not altogether surprising as the
lymphatic endothelium does have embryological origin
from the vascular system [2,3]. Similar mixed angioma-
tous patterns have been uncommonly recognized pre-
viously [4]. The specific marker for lymphatic
endothelium Lyve-1, a lymphatic vascular endothelial
receptor for hyaluronan, was not tested in our patient
but has been found also in vascular tumors like Kaposi’s
sarcoma [5]. Likewise, it has not been tested in malfor-
mations like this one for a discriminatory value.
The terminology and nosologic relationship of soft tis-
s u et u m o u r so ft h el y m p h a t i cs y s t e mc a nb ec o n f u s i n g .
Based on histopathological and clinical features, some
authors suggest a classification into lymphangioma, lym-
phangiectasia, diffuse lymphangiomatosis, lymphatic dys-
plasia syndrome, and a host of other miscellaneous
disorders [2]. Lymphangioma are focal proliferation of
well-differentiated lymphatic tissues that can be cystic as
in cystic hygroma. Primary lymphangiectasia presents in
neonates and are characterized by dilated lymphatic
channels that are remnants of otherwise normal fetal
lymphatics. In lymphangiomatosis there is multifocal
and more complex proliferation of mature lymphatic
capillaries. The proliferating lymphatics are infiltrative.
The dilated lymphatic channels may be of capillary size
to several centimeters and is surrounded by connective
tissue stroma containing lymphoid tissues and smooth
muscle cells. The surrounding tissues are infiltrated but
not destroyed.
Meanwhile, another cystic disease of the lungs, lym-
phangioleiomyomatosis, is an entirely different disorder
that is seen in premenopausal women where the prolif-
erating tissue destroys the surrounding lung tissues. The
cells in this disorder are estrogen-positive smooth mus-
cle cells [6].
Imaging with CT and magnetic resonance imaging
(MRI) may provide diagnostic information typical of dif-
fuse lymphangiomatosis [1]. The lytic lesions in the
bones have sharp margins without periosteal reaction.
Langerhans cell histiocytosis needs to be excluded in
children with multiple organ involvement and lytic
lesions in the bones. The thoracic involvement in diffuse
lymphangiomatosis may produce soft tissue mediastinal
mass, interstitial nodular lesions, and pericardial and
pleural involvement, as in our patient. The lesions are
isointense to muscle on T1-weighted images and hyper-
intense to fat on T2-weighted images on MRI, These do
not show strong contrast enhancement. Whole body
MRI with short tau inversion recovery sequence is con-
sidered a better method for delineating the extent of the
involvement of diffuse lymphangiomatosis [1].
The etiology of lymphangiomatosis remains unclear.
Recently, a number of growth factors that enhances
lymphogenesis have been identified, including VEGF-a,
VEGF-C, PDGF-BB, and angiopoeitin [6]. These findings
m a yh a v eat h e r a p e u t i cr o l e .I nf a c t ,t h et r e a t m e n to f
lymphangiomatosis with antiproliferative and anti-angio-
genetic drugs like interfero na l p h a2 aa n d2 bh a v ea l s o
been reported [7]. Long-term treatment for up to 30
months has been used, although the treatment is not
Figure 4 Lung biopsy (hematoxylin and eosin imaging) shows
multiple proliferating vascular spaces lined with endothelium
infiltrating in the interstitium. Lymphoid tissue is seen in the
stroma. Some of the spaces contain blood.
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some cases [8]. Thalidomide has been tried for its anti-
VEGF properties [9]. In the future, a better understand-
ing of the molecular mechanisms of proliferation and/or
triggers may lead to better outcomes.
Conclusion
In conclusion, diffuse lymphangiohemangiomatosis may
present with hemorrhagic pericardial effusion. A wider
appreciation of this multisystem disease is warranted.
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